Tanner Insights – Licensing, Acquisition & Commercialization
Opportunities in Latin America.
For pharma companies interested in product expansion, Latin America brings many opportunities for new entrants with a high demand for specialty pharmaceuticals, supplements and diagnostics – and some key untapped markets.
Whitepaper
WHY SHOULD I READ THIS WHITEPAPER?
- Pharma market insights for top LATAM regions
- Challenges associated with emerging markets
- Advantages for key stakeholders
- How Tanner Pharma can help
Download Insights
Leave your details below, and receive the requested content directly in your inbox.
For more information see our Privacy Policy.
Our Experience
20
20+ years of supporting patient access
150
Distribution experience in 1%0+ countries
68
Local resources across 68 countries
1,000 10,000 100,000 1,000,000
Patient lives impacted
OUR PROGRAMS
A range of access solutions to meet your challenges.
-
Licensing, Acquisitions and Commercialization: Commercializing licensed or acquired products via registration & promotion with a focus on Latin America.
-
Managed Access Programs: Enabling biopharmaceutical companies to run programs to supply patients in markets where a medicine does not have a marketing authorization or is not commercially accessible.
-
Clinical Trials Solutions: Sourcing, supply and logistics for biopharmaceutical companies requiring comparator, bioanalytical and biologic products for clinical trials.
-
Global Access Programs: Supporting physicians, hospitals and ministries of health across the globe by providing access to medicine via Named Patient Supply.
